Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability-Reference-Cited by-同舟云学术

Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability

Published:2020-10 Issue: Volume:292 Page:113321
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Espadas Cristina,Ballester Pura,Londoño Ana Carolina,Almenara Susana,Aguilar Víctor,Belda César,Pérez Enrique,Peiró Ana María

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference42 articles.

1. Psychopharmacological interventions in autism spectrum disorder;Accordino;Expert Opin. Pharmacother.,2016

2. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study;Adler;Autism,2015

3. Comorbidity burden in adults with autism spectrum disorders and intellectual disabilities–A report from the EFAAR (Frailty Assessment in Ageing Adults with Autism Spectrum and Intellectual Disabilities) study;Akbaraly;Front. Psychiatry,2019

4. Safety and Tolerability of Antipsychotic Medication in Individuals with Autism Spectrum Disorder: a Systematic Review and Meta-Analysis;Alfageh;Pediatric Drugs,2019

5. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders;Aman;Child Adolesc. Psychiatr. Clin. N. Am.,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Scoping Review of the Intersectionality of Autism and Intellectual and Developmental Disability with Social Inequity on Diagnosis and Treatment of Youth;Journal of Child and Adolescent Psychopharmacology;2024-07-03

2. Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability;Journal of Autism and Developmental Disorders;2024-01-14

3. Patterns of Mental Health Service Use During the Transition to Adulthood Among Autistic Adolescents and Young Adults;Autism in Adulthood;2023-12-01

4. Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study;Pharmaceuticals;2023-10-20

5. Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits;Frontiers in Psychiatry;2023-08-21